MR, S., SB, T., Y, B., V, A., & KA, S. (2020). Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: A regulatory perspective. Current opinion in HIV and AIDS, 15(1), 61. https://doi.org/10.1097/COH.0000000000000587
Chicago Style (17th ed.) CitationMR, Sampson, Troy SB, Belew Y, Arya V, and Struble KA. "Considerations and Challenges in Developing Novel Long-acting Antiretrovirals Modalities for Treatment and Prevention of HIV-1 Infection: A Regulatory Perspective." Current Opinion in HIV and AIDS 15, no. 1 (2020): 61. https://doi.org/10.1097/COH.0000000000000587.
MLA (9th ed.) CitationMR, Sampson, et al. "Considerations and Challenges in Developing Novel Long-acting Antiretrovirals Modalities for Treatment and Prevention of HIV-1 Infection: A Regulatory Perspective." Current Opinion in HIV and AIDS, vol. 15, no. 1, 2020, p. 61, https://doi.org/10.1097/COH.0000000000000587.